Somatostatin receptors in malignant tissues

Area of Science:

• Oncology
• Endocrinology
• Molecular Biology

Background:

• High-affinity somatostatin receptors (SS-R) are expressed in various human tissues.
• Understanding SS-R expression in tumors is crucial for targeted therapies.

Purpose of the Study:

• To investigate the presence and distribution of SS-R in a wide range of human tumors.
• To explore the functional implications of SS-R in tumor growth and hormone secretion.

Main Methods:

• Analysis of SS-R expression in human tumor samples using membrane homogenates and tissue sections.
• Autoradiography for assessing SS-R distribution in specific tumor types.
• In vivo imaging techniques using radiolabeled SS analogs.

Main Results:

• SS-R were identified in numerous human tumors, including pituitary, gastroenteropancreatic (GEP), brain, breast, lung, colorectal, and thyroid carcinomas.
• SS-R expression was often associated with well-differentiated tumors, neuroendocrine features, and low epidermal growth factor receptor (EGF-R) expression.
• SS-R mediate hormone secretion inhibition and antiproliferative effects in preclinical models, suggesting therapeutic potential.

Conclusions:

• High-affinity SS-R are widely expressed in human tumors, offering potential targets for diagnosis and therapy.
• SS-R status in tumors can be assessed using autoradiography and in vivo imaging.
• Somatostatin analogs show promise in inhibiting the growth of SS-R-expressing tumors.